Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
1,758,327
-
Share change
-
-18,040
-
Total reported value
-
$220,890,303
-
Put/Call ratio
-
27%
-
Price per share
-
$125.63
-
Number of holders
-
81
-
Value change
-
-$1,567,342
-
Number of buys
-
30
-
Number of sells
-
36
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2017
As of 30 Jun 2017 VANECK ETF TRUST - BIOTECH ETF (BBH) had 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,758,327 shares of stock of the company.
Largest 10 holders included ALLIANCEBERNSTEIN L.P., MORGAN STANLEY, UBS Group AG, ROYAL BANK OF CANADA, MURPHY CAPITAL MANAGEMENT INC, Endurant Capital Management LP, Strategic Financial Services, Inc,, BOSTON RESEARCH & MANAGEMENT INC, Cambridge Investment Research Advisors, Inc., and ASPIRIANT, LLC.
This table shows 81 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.